atir101
Cell therapyexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Oct 9, 2015 (NCT02500550)
Timeline
Indications
Mechanism of action
- T-lymphocytesSupplementation
T-lymphocytes supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- atir101
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02999854 | Phase 3 | May 1, 2017 | Kiadis Pharma, University of Montreal |
| NCT02500550 | Phase 2 | Oct 9, 2015 | Kiadis Pharma, University of Montreal |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Kiadis Pharma | For profit | 2 | 2 | 2 | 2015 |
| University of Montreal | Academic/Hospital | 2 | 0 | 2 | 2015 |
2 organizations
Page 1 / 1